TUNDRA TARGETED THERAPEUTICS, INC. — Form D
TUNDRA TARGETED THERAPEUTICS, INC. of MADISON, WI, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-03. The offering totals $3.0M, of which $444K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-06-03
- Form: D
- Accession: 0000892712-25-000073
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $444K
- Remaining: $2.6M
- Investors: 9
- Date of first sale: 2025-04-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-547896
Issuer
- Name: TUNDRA TARGETED THERAPEUTICS, INC.
- CIK: 0002070659
- Entity type: Corporation
- Jurisdiction: WISCONSIN
- Incorporated: 2021
- Address: 503 S PROSPECT AVE, MADISON, WI, 53711
- Phone: 608-333-1505
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| JEFFREY ARNOLD MEDIN | Director | MADISON, WI |
| BRIAN ARNOLD OLSON | Director | MADISON, WI |
| JAMES ARNOLD CARAGHER | Executive Officer | MADISON, WI |
| JEFFREY ARNOLD MEDIN | Executive Officer | MADISON, WI |
| BRIAN ARNOLD OLSON | Executive Officer | MADISON, WI |
| JEDIAH WILDER WHITE | Executive Officer | MADISON, WI |
More